29-MAY-2026 6:10

BREAST ACCRUAL REPORT - Open and Recently Closed Studies

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S2206-Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 Y 1 Tissue for MammaPrint testing 960 1058 529 263 139 42 6 11/27/2023 404 136
            1058 529 263 139 42 6      
 
    2 Y 2 SOC Chemotherapy   188 99 48 25 5 1 11/27/2023    
        3 SOC Chemotherapy + Durvalumab   188 103 51 29 7 2      
            376 202 99 54 12 3      
 
  S2212-Breast, TNBC, Neoadj Chemo + Pembro 1 Y 1 Carbo + Paclitaxel + Pembro -> AC + Pembro 2400 716 393 203 120 38 6 09/15/2023 433 157
        2 Carbo + Docetaxel + Pembro   714 389 203 117 37 6      
            1430 782 406 237 75 12      
 
Yes A011801-BRST, HER2+, T-DM1+Placebo v T-DM1+Tucatinib 1 E Total Registrations   55 0 0 0 0 0 03/11/2021 456 190
            55 0 0 0 0 0      
 
  A012103-Breast,StgT1cN1-2/T2-4N0-2,obsvsPembrolizumab 1 E Total Registrations   55 32 10 6 2 2 08/24/2023 442 188
            55 32 10 6 2 2      
 
  MA39-BREAST, Node-Pos, Reg RT vs No Reg RT 1 E Total Registrations   77 22 12 6 2 0 10/18/2019 403 148
            77 22 12 6 2 0      
 
    2 E Total Registrations   74 21 11 6 2 0 10/18/2019    
            74 21 11 6 2 0      
 
  NRGBR002-Brst, OMBC, II-III, SoC +/- SBRT and/or SA 1 T Total Registrations   1 0 0 0 0 0 09/22/2017 6 1
            1 0 0 0 0 0      
 
  NRGBR005-Br, Stg II&IIIA, Post NAdj Chemo Br Conserv 1 T Total Registrations   7 0 0 0 0 0 06/22/2018    
            7 0 0 0 0 0      
 
No A012303-Breast, HER2+, Shortened Adj 1 E Total Registrations   3 3 3 3 1 0 03/06/2026 45 16
            3 3 3 3 1 0      
 
  NRGBR009-Breast, EarlyStg, Adjuvant Chemo 1 E Total Registrations   51 37 20 8 4 0 01/31/2024 523 199
            51 37 20 8 4 0      
 
    2 E Total Registrations   43 29 15 8 3 0 01/31/2024    
            43 29 15 8 3 0